Madrigal pharmaceuticals appoints mardi c. dier as chief financial officer

Conshohocken, pa., feb. 28, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today announced that mardi c. dier has been appointed chief financial officer.
MDGL Ratings Summary
MDGL Quant Ranking